Review
doi: 10.1007/BF01556584.
Chemotherapy of malignant melanoma
- PMID: 382646
- DOI: 10.1007/BF01556584
Item in Clipboard
Review
Chemotherapy of malignant melanoma
World J Surg.
.
No abstract available
Similar articles
-
[Fotemustine in the treatment of metastatic malignant melanoma. Overall analysis of results].Pathol Biol (Paris). 1990 Oct;38(8):876-80. Pathol Biol (Paris). 1990. PMID: 2274396 French. No abstract available.
-
DTIC (NSC-45388) in malignant melanoma: a perspective.Cancer Treat Rep. 1976 Feb;60(2):165-76. Cancer Treat Rep. 1976. PMID: 769969 Review. No abstract available.
-
Single drug and combination chemotherapy in the treatment. Disseminated malignant melanoma.Minn Med. 1977 Aug;60(8):543-8. Minn Med. 1977. PMID: 882082 No abstract available.
-
Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma.Cancer Treat Rev. 1974 Dec;1(4):285-304. doi: 10.1016/s0305-7372(74)80020-4. Cancer Treat Rev. 1974. PMID: 4619579 Review. No abstract available.
-
Adjuvant chemoimmunotherapy stage I/II malignant melanoma.J Surg Oncol. 1982 Mar;19(3):165-70. doi: 10.1002/jso.2930190311. J Surg Oncol. 1982. PMID: 7040820 Clinical Trial. No abstract available.
Cited by
-
The evolution in melanoma treatment as a reflection of precision-oriented medicine.Oncol Lett. 2013 Feb;5(2):424-426. doi: 10.3892/ol.2012.1065. Epub 2012 Dec 5. Oncol Lett. 2013. PMID: 23420786 Free PMC article.
-
Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma.Invest New Drugs. 1987;5(3):293-7. doi: 10.1007/BF00175301. Invest New Drugs. 1987. PMID: 3667165